AIDS Researchers Isolate New Potent and Broadly Effective Antibodies Against HIV Discovery provides new directions for AIDS vaccine design

IAVI, The Scripps Research Institute, Theraclone Sciences and Monogram Biosciences (a LabCorp company), published in the journal, Nature, today the discovery of 17 new broadly neutralizing antibodies against HIV. Together these discoveries with other recent discoveries in the neutralizing antibody arena represent tremendous progress in this area of AIDS vaccine research.  The IAVI announcement is available below.

Global HIV Vaccine Enterprise, 64 Beaver Street, # 352, New York, NY 10004 | +1 212-461-3692 or toll free at +1-866-966-4483
All Content ©2005 - 2013 Global HIV Vaccine Enterprise   |   Terms of Use   |   Privacy Policy   |   Log In / My Account